Literature DB >> 30888938

Sugammadex is changing the paradigm in neuromuscular blockade in patients with myotonic dystrophy.

Joana Teixeira1, Bernardo Matias1, Irene Ferreira1, Tiago Taleço1, João S Duarte1.   

Abstract

Entities:  

Keywords:  Myotonic dystrophy type 1; Neuromuscular blockade reversal; Neuromuscular diseases; Rocuronium; Sugammadex

Year:  2019        PMID: 30888938     DOI: 10.1177/1750458919838412

Source DB:  PubMed          Journal:  J Perioper Pract        ISSN: 1750-4589


× No keyword cloud information.
  1 in total

1.  Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Authors:  Usha Gurunathan; Shakeel Meeran Kunju; Lisa May Lin Stanton
Journal:  BMC Anesthesiol       Date:  2019-11-19       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.